Nedd8 on cullin: building an expressway to protein destruction.

Zhen-Qiang Pan , Alex Kentsis , Dora C Dias , Kosj Yamoah
Oncogene 23 ( 11) 1985 -1997

465
2004
MOLECULAR AND STRUCTURAL IMMUNOLOGY-Definition of Minimal Domains of Interaction Within the Recombination-Activating Genes 1 and 2 Recombinase Complex

Vassilis Aidinis , Dora C Dias , Carlos A Gomez , Debika Bhattacharyya
Journal of Immunology 164 ( 11) 5826 -5832

2000
CUL7: A DOC domain-containing cullin selectively binds Skp1⋅Fbx29 to form an SCF-like complex

Dora C Dias , Georgia Dolios , Rong Wang , Zhen-Qiang Pan
Proceedings of the National Academy of Sciences of the United States of America 99 ( 26) 16601 -16606

124
2002
CUL7 assembles a non-traditional SCF-like E3 ubiquitin ligase that interacts with p53

Dora C Dias
Mount Sinai School of Medicine of New York University

2004
KIT mutations and CD117 overexpression are markers of better progression‐free survival in vulvar melanomas

D. Dias‐Santagata , M.A. Selim , Y. Su , Y. Peng
British Journal of Dermatology 177 ( 5) 1376 -1384

10
2017
Frequent Mutation of Isocitrate Dehydrogenase (IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping

Darrell R. Borger , Kenneth K. Tanabe , Kenneth C. Fan , Hector U. Lopez
Oncologist 17 ( 1) 72 -79

748
2012
Complete Remission Following Pembrolizumab in a Woman with Mismatch Repair‐Deficient Endometrial Cancer and a Germline BRCA1 Mutation

Don S. Dizon , Dora Dias‐Santagata , Amy Bregar , Laura Sullivan
Oncologist 23 ( 6) 650 -653

6
2018
Clinically Integrated Molecular Diagnostics in Adenoid Cystic Carcinoma

Julia Thierauf , Nisha Ramamurthy , Vickie Y. Jo , Hayley Robinson
Oncologist 24 ( 10) 1356 -1367

7
2019
Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine

Dora Dias‐Santagata , Sara Akhavanfard , Serena S. David , Kathy Vernovsky
Embo Molecular Medicine 2 ( 5) 146 -158

340
2010
The tumor suppressor WTX is inactivated in a subset of pediatric tumors

Sara Akhavanfard , Miguel N Rivera , Dora C Dias-Santagata , Sara O Vargas
Cancer Research 71 ( 8_Supplement) 4349 -4349

2011
Real Time Targeted Mutational Analysis of Human Tumors: a Clinical Platform to Guide Personalized Cancer Medicine

DC Dias-Santagata , S Akhavanfard , SS David , K Vemovsky
JOURNAL OF MOLECULAR DIAGNOSTICS 11 ( 6) 666 -666

2009
Pathway Interplay: Activation of EGFR, ERK, and AKT in Early-Stage Lung Adenocarcinomas

AE Kovach , V Morales-Oyarvide , DE Shvetz , S Tammireddy
LABORATORY INVESTIGATION 93 457A -457A

2013
Methods and materials for genetic analysis of tumors

Anthony John Iafrate , Dora Dias-Santagata

22
2010
Intraductal Carcinoma of the Salivary Gland with NCOA4-RET: Expanding the Morphologic Spectrum and an Algorithmic Diagnostic Approach.

Peter M. Sadow , Peter M. Sadow , Dora Dias-Santagata , Daniel G. Deschler
Human Pathology

2021
Cribriform-Morular Thyroid Carcinoma Is a Distinct Thyroid Malignancy of Uncertain Cytogenesis.

Peter M Sadow , Dora Dias-Santagata , Sylvia L Asa , Ozgur Mete
Endocrine Pathology

17
2021
Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC

Alexa B. Turke , Kreshnik Zejnullahu , Yi-Long Wu , Youngchul Song
Cancer Cell 17 ( 1) 77 -88

797
2010
Synthetic lethal interaction of combined BCL-XL and MEK inhibition promotes tumor regressions in KRAS mutant cancer models.

Ryan B Corcoran , Katherine A Cheng , Aaron N Hata , Anthony C Faber
Cancer Cell 23 ( 1) 121 -128

376
2013
Mutational analysis and clinical correlation of metastatic colorectal cancer.

Andrea L. Russo , Darrell R. Borger , Jackie Szymonifka , David P. Ryan
Cancer 120 ( 10) 1482 -1490

49
2014